How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Sepsis results in complex alterations to the immune system. Our understanding of how these alterations in immune responses could help characterize extreme immune phenotypes, identify biomarkers with the ability to stratify patients for therapeutic interventions, surrogates in the causal pathway of clinical end-points, and treatable traits are still rudimentary. A methodologically rigorous, consensus-based approach should enrich sepsis immune subpopulations to increase the probability of successful trials.

Author supplied keywords

Cite

CITATION STYLE

APA

Shankar-Hari, M. (2017, May 26). How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis? Critical Care. BioMed Central Ltd. https://doi.org/10.1186/s13054-017-1715-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free